These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20529796)

  • 41. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
    Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies, immunogenicity, and associated infusion reactions.
    Cheifetz A; Mayer L
    Mt Sinai J Med; 2005 Jul; 72(4):250-6. PubMed ID: 16021319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bugged.
    Ayling J
    Emerg Med Serv; 2003 May; 32(5):48. PubMed ID: 12776412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse reactions to contrast material: recognition, prevention, and treatment.
    Maddox TG
    Am Fam Physician; 2002 Oct; 66(7):1229-34. PubMed ID: 12387435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and characteristics of biphasic and protracted anaphylaxis: evaluation of 114 inpatients.
    Oya S; Nakamori T; Kinoshita H
    Acute Med Surg; 2014 Oct; 1(4):228-233. PubMed ID: 29930853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biphasic and protracted anaphylaxis to iodinated contrast media.
    Kim TH; Yoon SH; Lee SY; Choi YH; Park CM; Kang HR; Cho SH
    Eur Radiol; 2018 Mar; 28(3):1242-1252. PubMed ID: 28956131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.
    Isabwe GAC; Garcia Neuer M; de Las Vecillas Sanchez L; Lynch DM; Marquis K; Castells M
    J Allergy Clin Immunol; 2018 Jul; 142(1):159-170.e2. PubMed ID: 29518427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biphasic anaphylactic reactions: occurrence and mortality.
    Rohacek M; Edenhofer H; Bircher A; Bingisser R
    Allergy; 2014 Jun; 69(6):791-7. PubMed ID: 24725226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer.
    Ruggiero A; Triarico S; Trombatore G; Battista A; Dell'acqua F; Rizzari C; Riccardi R
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1739-46. PubMed ID: 23765411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "Not so immediate" hypersensitivity--the danger of biphasic anaphylactic reactions.
    Brazil E; MacNamara AF
    J Accid Emerg Med; 1998 Jul; 15(4):252-3. PubMed ID: 9681309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.
    Cmelak AJ; Lordick F; Borner M; Goldberg RM; Saif MW
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl 1):18-25. PubMed ID: 19385163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Early Detection of and Initial Response to Oxaliplatin-Related Hypersensitivity Reactions].
    Taniguchi J; Itonaga S; Kanazawa E; Murakami M; Saeki A; Hashimoto M
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):61-65. PubMed ID: 32381864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibodies: longitudinal prescribing information analysis of hypersensitivity reactions.
    Kleyman K; Weintraub DS
    MAbs; 2012; 4(3):392-7. PubMed ID: 22531444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allergic Reactions Captured by Voluntary Reporting.
    Blumenthal KG; Wolfson AR; Li Y; Seguin CM; Phadke NA; Banerji A; Mort E
    J Patient Saf; 2021 Dec; 17(8):e1595-e1604. PubMed ID: 30720546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The essentials of chemotherapy-induced infusion reactions.
    Zetka ES
    Clin J Oncol Nurs; 2012 Oct; 16(5):527-9. PubMed ID: 23022937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between biphasic reactions and the systems of symptoms and treatment in patients with anaphylaxis hospitalized from the emergency department.
    Nomura T; Sekii H; Sugita M; Nakahara S
    Acute Med Surg; 2020; 7(1):e599. PubMed ID: 33209335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biphasic and protracted anaphylaxis.
    Stark BJ; Sullivan TJ
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):76-83. PubMed ID: 3722636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study.
    Ichikawa M; Kuriyama A; Urushidani S; Ikegami T
    Acute Med Surg; 2021; 8(1):e689. PubMed ID: 34354840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute Infusion-Related Reactions: How to Recognize and Intervene When These Reactions Occur in Practice.
    Price M
    Clin J Oncol Nurs; 2021 Oct; 25(5):591-594. PubMed ID: 34533514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events.
    Gülsen A; Wedi B; Jappe U
    Allergo J Int; 2020; 29(4):97-125. PubMed ID: 32421085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.